Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.
Linazasoro
Gurutz
G
Centro de Neurología y Neurocirugía funcional, Clínica Quirón, San Sebastián, Spain. glinazasoro@terra.es
Van Blercom
Nadege
N
Castro
Alfonso
A
Dapena
Maria Dolores
MD
D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003244:Consciousness Disorders / Q000209:etiology; D003620:Dantrolene / Q000627:therapeutic use; D046690:Deep Brain Stimulation; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D020821:Dystonic Disorders / Q000209:etiology; D004660:Encephalitis / Q000175:diagnosis; D005260:Female; D005440:Fluid Therapy; D005528:Foot; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008305:Malignant Hyperthermia / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy / Q000601:surgery*; D012642:Selegiline / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D013610:Tachycardia / Q000209:etiology
D018712:Analgesics, Non-Narcotic; D000890:Anti-Infective Agents; D000978:Antiparkinson Agents; D009125:Muscle Relaxants, Central; D012642:Selegiline; D007980:Levodopa; D003620:Dantrolene